PublishedOpen AccessResearch PaperTransparent Peer ReviewedCC BY 4.0
ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open
Paper Title
TERATOGENIC RISK OF DRUGS USED IN EARLY PREGNANCY
Authors
S. Karthikeyan , Dr.Nallanayagam
Keywords
Teratogenesis , Malformation , Anti epileptic drugs, Risk factors
Abstract
Treatment of common illnesses in early pregnancy is complicated because of the risk of teratogenic effects of drugs on the fetus. The period of greatest risk is between the first and eighth week of pregnancy. Since much of this period occurs before a diagnosis of pregnancy is made, care must be used in treatment of common illnesses in all women susceptible to becoming pregnant. Few, if any, drugs have been tested for teratogenicity in controlled clinical trials. Risk must therefore be based on epidemiological studies, individual case reporting and extrapolation from animal studies. Sufficient information is available on commonly used drugs to establish such risks. It is important that drugs of least known risk but adequate efficacy be used in treating intercurrent illness in the first trimester
Choose the style your journal or department asks for, then copy it.
Every version below is generated from this paper's own record.
IJRTI — journal style
"TERATOGENIC RISK OF DRUGS USED IN EARLY PREGNANCY", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.6, Issue 3, page no.27 - 32, March-2021, Available :https://ijrti.org/papers/IJRTI2103007.pdf
APA — 7th edition
Karthikeyan, S., & Dr.Nallanayagam. (2021). TERATOGENIC RISK OF DRUGS USED IN EARLY PREGNANCY. International Journal for Research Trends and Innovation, 6(3), 27 - 32. https://ijrti.org/viewpaperforall.php?paper=IJRTI2103007
MLA — 9th edition
Karthikeyan, S., and Dr.Nallanayagam. "TERATOGENIC RISK OF DRUGS USED IN EARLY PREGNANCY." International Journal for Research Trends and Innovation, vol. 6, no. 3, 2021, pp. 27 - 32, https://ijrti.org/viewpaperforall.php?paper=IJRTI2103007.
Chicago — 17th, bibliography
Karthikeyan, S., and Dr.Nallanayagam. "TERATOGENIC RISK OF DRUGS USED IN EARLY PREGNANCY." International Journal for Research Trends and Innovation 6, no. 3 (2021): 27 - 32. https://ijrti.org/viewpaperforall.php?paper=IJRTI2103007.
Harvard — author–date
Karthikeyan, S. and Dr.Nallanayagam (2021) 'TERATOGENIC RISK OF DRUGS USED IN EARLY PREGNANCY', International Journal for Research Trends and Innovation, 6(3), pp. 27 - 32. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2103007
IEEE — numbered reference
S. Karthikeyan and Dr.Nallanayagam, "TERATOGENIC RISK OF DRUGS USED IN EARLY PREGNANCY," IJRTI, vol. 6, no. 3, pp. 27 - 32, Mar. 2021.
Vancouver — biomedical
Karthikeyan S, Dr.Nallanayagam. TERATOGENIC RISK OF DRUGS USED IN EARLY PREGNANCY. IJRTI. 2021 Mar;6(3):27 - 32.
AMA — 11th edition
Karthikeyan S, Dr.Nallanayagam. TERATOGENIC RISK OF DRUGS USED IN EARLY PREGNANCY. IJRTI. 2021;6(3):27 - 32. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2103007
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2103007,
author = {S. Karthikeyan and Dr.Nallanayagam},
title = {TERATOGENIC RISK OF DRUGS USED IN EARLY PREGNANCY},
journal = {International Journal for Research Trends and Innovation},
volume = {6},
number = {3},
pages = {27 - 32},
year = {2021},
month = {March},
issn = {2456-3315},
url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2103007}
}
RIS — EndNote, RefWorks
TY - JOUR
AU - Karthikeyan, S.
AU - Dr.Nallanayagam
TI - TERATOGENIC RISK OF DRUGS USED IN EARLY PREGNANCY
T2 - International Journal for Research Trends and Innovation
JA - IJRTI
VL - 6
IS - 3
PY - 2021
SN - 2456-3315
UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2103007
SP - 27
EP - 32
ER -
International Journal for Research Trends and InnovationPublished by IJRTI (JW Publication)
2456-3315ISSN
10.57Impact Factor
2016ESTD Year
OpenAccess
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.
Disclaimer:
The content, data and findings in this article are based on the authors’ research and have been
peer-reviewed for academic purposes only. Readers are advised to verify all information before practical
or commercial use. The journal and its editorial board are not liable for any errors, losses or
consequences arising from its use.
Declarations
Funding
No external funding was received for this study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Acknowledgements
The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.